Product Information
RELISTOR 8 MG/0.4 ML SYRINGE is a brand product labeled by Salix Pharmaceuticals Inc., priced at $409.7653 per ML under NDC 65649055204. Its NADAC has been published 220 times since Nov 19, 2014.
Strength
8 mg/.4mL
Manufacturer
Salix Pharmaceuticals Inc.NDC
65649055204
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/1/2025
Active Ingredients
METHYLNALTREXONE BROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA021964On Market Since
4/24/2008
Pharmacological Classes
Price Statistics
The NADAC for RELISTOR 8 MG/0.4 ML SYRINGE has been published 220 times since Nov 19, 2014, and over the history we have for it it has risen 158.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $409.7653 per ML |
|---|---|
| All-time high | $409.7653 (Oct 1, 2025) |
| All-time low | $158.3893 (Nov 19, 2014) |
| 52-week high | $409.7653 |
| 52-week low | $409.7653 |
| Median price | $264.8895 |
| Average price | $284.3613 |
| Largest weekly change | +45.7% (May 22, 2024) |
| Weeks tracked | 220 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Methylnaltrexone bromide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RELISTOR 8 MG/0.4 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for RELISTOR 8 MG/0.4 ML SYRINGE, manufactured by Salix Pharmaceuticals Inc., is $409.7653 per ML (NDC 65649055204), effective Oct 1, 2025.
How has the price of RELISTOR 8 MG/0.4 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for RELISTOR 8 MG/0.4 ML SYRINGE has risen 158.7%. It has been tracked across 220 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for RELISTOR 8 MG/0.4 ML SYRINGE?
Since Nov 19, 2014, the NADAC for RELISTOR 8 MG/0.4 ML SYRINGE has ranged from a low of $158.3893 (Nov 19, 2014) to a high of $409.7653 (Oct 1, 2025), with a median of $264.8895 per ML.
Are there cheaper alternatives to RELISTOR 8 MG/0.4 ML SYRINGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RELISTOR 8 MG/0.4 ML SYRINGE, so no direct lower-cost alternative is listed.
Who manufactures RELISTOR 8 MG/0.4 ML SYRINGE?
RELISTOR 8 MG/0.4 ML SYRINGE (NDC 65649055204) is labeled by Salix Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification